1. Clinical Overview
Betahistine is a histamine analogue and a potent H1 receptor agonist with weak H3 receptor antagonist activity. It is primarily used for the symptomatic management of vertigo and Meniere's disease. In the Indian context, it is a first-line prophylactic and therapeutic agent for vestibular disorders, widely prescribed by ENT specialists and neurologists.
| Onset | Duration | Bioavailability |
|---|---|---|
| Oral: Within 30 to 60 minutes. | Approximately 3 to 6 hours. | Approximately 90% after oral administration. |
2. Mechanism of Action
Betahistine exerts its therapeutic effect primarily by improving microcirculation in the inner ear (cochlear blood flow) and by modulating neuronal activity in the vestibular nuclei. It acts as a partial agonist at postsynaptic histamine H1 receptors in the inner ear, leading to vasodilation of the precapillary sphincters in the stria vascularis. Concurrently, its antagonistic action at presynaptic histamine H3 autoreceptors increases the release of histamine from histaminergic neurons, further potentiating H1-mediated vasodilation and exerting a central inhibitory effect on vestibular nuclei activity.
3. Indications & Uses
- Meniere's disease (for reduction of frequency and severity of vertigo attacks)
- Vertigo of peripheral vestibular origin (e.g., Benign Paroxysmal Positional Vertigo - BPPV, vestibular neuronitis, labyrinthitis)
4. Dosage & Administration
Adult Dosage: For Meniere's syndrome/Vertigo: Initially, 8 mg orally three times daily (24 mg/day). Maintenance: 24 mg to 48 mg per day in divided doses (e.g., 16 mg three times daily). The dose should be individualized.
Administration: Administer with or without food. Tablets should be swallowed whole with a glass of water. For best results, take at regular intervals. Therapy is usually long-term for Meniere's disease.
5. Side Effects
Common side effects may include:
- Headache
- Mild gastrointestinal disturbances (dyspepsia, nausea, abdominal bloating)
- Skin rash or pruritus
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Antihistamines (e.g., Cetirizine, Loratadine, Diphenhydramine) | May antagonize the therapeutic effect of betahistine at H1 receptors, reducing efficacy. | Major |
| Monoamine Oxidase Inhibitors (MAOIs) e.g., Phenelzine, Selegiline | May potentiate the effects of betahistine by inhibiting its metabolism, increasing risk of adverse effects like headache and hypertension. | Major |
| Antihypertensives | Betahistine may cause vasodilation and potentiate the blood pressure-lowering effect, leading to hypotension. | Moderate |
| Sympathomimetics (e.g., Pseudoephedrine) | Additive vasoconstrictive effects may theoretically counteract betahistine's action; clinical significance unclear. | Moderate |
7. Patient Counselling
- DO take the medication exactly as prescribed by your doctor, usually 2-3 times daily.
- DO inform your doctor if you have a history of asthma, ulcers, or kidney/liver problems.
- DO report any severe headache, rash, or difficulty breathing immediately.
- DONT stop the medication abruptly if you have been taking it for a long time; consult your doctor.
- DONT take over-the-counter antihistamines (cold/allergy medicines) without consulting your doctor or pharmacist.
8. Toxicology & Storage
Overdose: Symptoms may include severe nausea, vomiting, abdominal pain, drowsiness, seizures (rare), hypotension or hypertension, and respiratory distress.
Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep out of reach of children. Do not use after the expiry date printed on the pack.